Deferoxamine Mesylate Injection, Powder, Lyophilized, For Solution
Product Images NDC 0409-2337

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Deferoxamine Mesylate (NDC 0409-2337). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula Deferoxamine Mesylate (Deferoxamine 01)

Chemical structure of deferoxamine mesylate showing the arrangement of its molecular components, including amine groups, carbon chains, and mesylate moiety.*

FDA Label Image

Hospira Logo (Deferoxamine 02)

FDA Label Image

Principal Display Panel (500 mg Vial Label)

Label for Deferoxamine Mesylate 500 mg per vial injection, USP presented as a single-dose vial for intravenous, intramuscular, and subcutaneous use. The label includes storage instructions, a barcode, NDC 0409-2336-01, and the distributor Hospira, Inc., Lake Forest, IL.*

FDA Label Image

Principal Display Panel (500 mg Vial Carton)

Label for Deferoxamine Mesylate for Injection, USP 500 mg/vial by Hospira, Inc. The package contains 4 single-dose vials. It includes dosing and storage instructions, bar code, and states the product is made in Hungary and distributed by Hospira, Inc. The label mentions use via intravenous, intramuscular, or subcutaneous routes and highlights reconstitution guidelines.*

FDA Label Image

Principal Display Panel (2 g Vial Label)

Label for Deferoxamine Mesylate for Injection, USP 2 g per vial, produced by Hospira, Inc. The label indicates it is a single-dose fliptop vial for subcutaneous, intramuscular, or intravenous use. Storage instructions specify keeping at 20 to 25°C with discard guidelines for unused portions.*

FDA Label Image

Principal Display Panel (2 g Vial Carton)

Packaging label for Deferoxamine Mesylate for Injection, USP, 2 g/vial by Hospira, Inc. The label indicates it contains 4 flitop vials with lyophilized deferoxamine mesylate. Usage instructions include subcutaneous, intramuscular, or intravenous administration, single-dose only. Storage directions specify room temperature (20 to 25°C). The product is made in Hungary.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.